Paper Details

  1. Home
  2. Paper Details

Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.

Author: CoboC, De CréeJ, GeukensH, VerhaegenH

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Nebivolol, a beta 1-selective adrenergic antagonist, improved left ventricular compliance, potentially by combined effects on preload and afterload.
Paper Details　
Original Abstract of the Article :
In an observer-blind four-way crossover study, 7 healthy volunteers received in random sequence, one month apart, atenolol 100 mg od, propranolol (slow release) 160 mg od, pindolol 5 mg tid, and nebivolol 5 mg od for a period of seven days, followed by a single-blind placebo washout period of seven ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/000331979004100202

データ提供：米国国立医学図書館（NLM）

Comparing Beta-Blockers: Navigating the Cardiovascular Desert

Beta-blockers are a class of medications commonly used to treat high blood pressure and other cardiovascular conditions. This study focuses on comparing the subacute hemodynamic effects of four different beta-blockers: atenolol, propranolol, pindolol, and nebivolol. The researchers aim to identify any differences in the way these medications affect the cardiovascular system.

Nebivolol Demonstrates Unique Hemodynamic Profile

The study involved a four-way crossover trial with healthy volunteers receiving each beta-blocker for a week, followed by a placebo washout period. The researchers found that all four beta-blockers effectively reduced heart rate and blood pressure during exercise. However, nebivolol showed a unique hemodynamic profile, demonstrating a more favorable effect on left ventricular function compared to the other three beta-blockers. This suggests that nebivolol might offer additional benefits beyond just reducing heart rate and blood pressure, potentially improving overall cardiovascular health.

Choosing the Right Beta-Blocker

This research emphasizes the importance of considering the individual needs and characteristics of patients when choosing the right beta-blocker. Just as a camel chooses the most suitable path through the desert, healthcare providers should carefully select the beta-blocker that best suits a patient's specific health condition and potential side effects. This personalized approach can lead to better treatment outcomes and a higher quality of life for patients with cardiovascular conditions.

Dr. Camel's Conclusion

This study provides a detailed analysis of the subacute hemodynamic effects of different beta-blockers, revealing the unique profile of nebivolol, which offers potential benefits for left ventricular function. The findings reinforce the importance of considering individual needs and tailoring treatment plans accordingly. As we continue to explore the intricacies of the cardiovascular system, we're gaining a more nuanced understanding of the potential benefits and risks associated with various medications.

Date :
  1. Date Completed 1990-03-27
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

1968323

DOI: Digital Object Identifier

10.1177/000331979004100202

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.